As of August 28, 2026, Anika Therapeutics, Inc. (ANIK) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Anika Therapeutics, Inc. has a market capitalization of $193.33M, 13.38M shares outstanding, 129 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ANIK.
Market Data
Market Cap$193.33M
Shares Outstanding13.38M
Float11.28M
Cash$64.18M
Debt$26.60M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 20.7% shares (2026Q1 vs prior)
129 institutional holders · 14.79M shares
#1
MORGAN STANLEY
2.04M shares
#2
BlackRock, Inc.
1.59M shares
#3
Caligan Partners LP
1.44M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest307.6K
Days to Cover4.3
% of Float2.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
4
INSIDER TRANSACTION
2026-03-23
4
INSIDER TRANSACTION
2026-03-17
4
INSIDER TRANSACTION
2026-03-17
4
INSIDER TRANSACTION
2026-03-17
4
INSIDER TRANSACTION
2026-03-17
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ANIK Dilution Snapshot
Anika Therapeutics, Inc. (ANIK) has a DilutionScore of 23/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ANIK: 4 on 2026-03-23; 4 on 2026-03-17; 4 on 2026-03-17.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ANIK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANIK — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ANIK
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.